Ask AI
Bill106th CongressFiled Sep 20, 2000Health
H.R. 5235

Prescription Drug Competition Act of 2000

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in house (Sep 20, 2000)

Prescription Drug Competition Act of 2000 - Requires a brand name drug company and a generic drug applicant that enter into an agreement regarding the sale or manufacture of a generic drug determined or likely to be the therapeutic equivalent of such brand name drug, when such agreement could limit the research, development, manufacture, marketing, or sale of such generic drug, to file with the Federal Trade Commission and the Secretary of Health and Human Services the text of such agreement and an explanation of whether such agreement could delay, restrain, limit, or otherwise interfere with the production, manufacture, or sale of the generic drug in question. Requires such filing within ten days of agreement execution. Provides civil penalties for violation.

What just happenedOct 20, 2000

Referred to the Subcommittee on Health and Environment.

Who’s behind it

Rep. Waxman, Henry A. [D-CA-29](D-CA)Sponsor
5 cosponsors4 D1 R
Read on Congress.gov
5cosponsors2committees7actions14subjects
  1. Oct 20, 2000CommitteeH11000

    Referred to the Subcommittee on Health and Environment.

    Health and Environment Subcommittee
  2. Sep 20, 2000IntroReferralH11100

    Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  3. Sep 20, 2000IntroReferralH11100-A

    Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Sep 20, 2000IntroReferralH11100

    Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  5. Sep 20, 2000IntroReferralB00100

    Sponsor introductory remarks on measure. (CR E1538)

  6. Sep 20, 2000IntroReferralIntro-H

    Introduced in House

  7. Sep 20, 2000IntroReferral1000

    Introduced in House